Nurix Therapeutics officer proposes $123K share sale

The notice lists Morgan Stanley Smith Barney LLC as broker and reports 2,834 common shares sold during the preceding three months.

Available on EDGAR 11/04/2026 - 04:24 PM EST Accepted by SEC EDGAR 11/04/2026 - 04:24 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Nurix Therapeutics, Inc. (NRIX) officer Johannes van Houte reported a proposed sale of 4,769 common shares, with an aggregate market value of $123,135.58 and an approximate sale date of November 4, 2026. Morgan Stanley Smith Barney LLC is listed as broker and NASDAQ as the exchange. The notice also reports 2,834 common shares sold for $74,474.97 during the prior three months and lists 4,769 common shares acquired from the issuer on October 30, 2026, in a transaction described as restricted stock units.

Key Figures

Proposed sale: 4,769 shares Aggregate market value: $123,135.58 Prior three-month sales: 2,834 shares +2 more

5 metrics

Proposed sale 4,769 shares Common shares; approximate sale date November 4, 2026

Aggregate market value $123,135.58 Proposed sale

Prior three-month sales 2,834 shares Common shares sold October 30, 2026

Value of prior three-month sales $74,474.97 Common shares sold October 30, 2026

Shares acquired from issuer 4,769 shares Common shares; transaction described as restricted stock units on October 30, 2026

Key Terms

Rule 144, Restricted Stock Units

2 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NRIX shares did Johannes van Houte propose to sell?

Johannes van Houte reported a proposed sale of 4,769 NRIX common shares, with an aggregate market value of $123,135.58 and an approximate sale date of November 4, 2026. Morgan Stanley Smith Barney LLC is listed as broker, and NASDAQ as the exchange.

How many NRIX shares did Johannes van Houte sell in the prior three months?

The notice lists Johannes van Houte as having sold 2,834 NRIX common shares on October 30, 2026, for $74,474.97 during the three-month period covered.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001817217
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NURIX THERAPEUTICS, INC.
SEC File Number	001-39398
Address of Issuer	1600 Sierra Point Parkway Brisbane CALIFORNIA 94005
Phone	4156605320
Name of Person for Whose Account the Securities are To Be Sold	JOHANNES VAN HOUTE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4769	123135.58	109249814	11/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/30/2026	Restricted Stock Units	Issuer			4769	10/30/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JOHANNES VAN HOUTE 1600 Sierra Point Parkway Brisbane CA 94005	Common	10/30/2026	2834	74474.97

144: Remarks and Signature

Remarks
Date of Notice	11/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/03/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Johannes van Houte
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)